Insilico Medicine Partners with UAE for AI Drug Discovery

Insilico Medicine advances Middle East push with UAE AI drug discovery deal

Hong Kong-listed Insilico Medicine has signed a cooperation agreement with the United Arab Emirates’ drug regulator to advance the use of its artificial intelligence tools in drug discovery across the region, even as geopolitical tensions escalate in the Middle East. Shares of Insilico rose as much as 12.8 per cent in morning trading on Thursday before paring gains to close 8.6 per cent higher at HK$56.10. The advance outpaced the benchmark Hang Seng Index, which edged up 0.3 per cent. The...

By Julie Zhang